Search research articles
Contact Us
Filters
Showing results (51-60 of 157) with videos related to
Page
of 16
Sort By:
The Journal of Biological Chemistry
|
April 30, 2016
Characterization of the Interactions between Calmodulin and Death Receptor 5 in Triple-negative and Estrogen Receptor-positive Breast Cancer Cells: AN INTEGRATED EXPERIMENTAL AND COMPUTATIONAL STUDY
Romone M Fancy, Lingyun Wang, Qinghua Zeng, et al.
Plos One
|
March 8, 2013
The C-terminal region Mesd peptide mimics full-length Mesd and acts as an inhibitor of Wnt/β-catenin signaling in cancer cells
Cuihong Lin, Wenyan Lu, Wei Zhang, et al.
Pancreas
|
February 26, 2010
A new drug delivery method of bispecific ligand-directed toxins, which reduces toxicity and promotes efficacy in a model of orthotopic pancreatic cancer
Seunguk Oh, Brad J Stish, Selwyn M Vickers, et al.
Cancer Letters
|
April 16, 2014
Multi-targeted therapy of cancer by niclosamide: A new application for an old drug
Yonghe Li, Pui-Kai Li, Michael J Roberts, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 14, 2008
Enhancement of glioma radiotherapy and chemotherapy response with targeted antibody therapy against death receptor 5
John B Fiveash, G Yancey Gillespie, Patsy G Oliver, et al.
The Journal of Surgical Research
|
July 10, 2003
Differential responses by pancreatic carcinoma cell lines to prolonged exposure to Erbitux (IMC-C225) anti-EGFR antibody
Zhi-qiang Huang, Donald J Buchsbaum, Kevin P Raisch, et al.
International Journal of Molecular Sciences
|
March 22, 2018
<sup>212</sup>Pb-Labeled Antibody 225.28 Targeted to Chondroitin Sulfate Proteoglycan 4 for Triple-Negative Breast Cancer Therapy in Mouse Models
Benjamin B Kasten, Patsy G Oliver, Harrison Kim, et al.
Herpes : the Journal of the IHMF
|
December 7, 2006
Oncolytic HSV-1 for the treatment of brain tumours
James M Markert, Jacqueline N Parker, Donald J Buchsbaum, et al.
International Journal of Molecular Sciences
|
May 23, 2018
Preferential Inhibition of Wnt/β-Catenin Signaling by Novel Benzimidazole Compounds in Triple-Negative Breast Cancer
Abhishek Gangrade, Vibha Pathak, Corinne E Augelli-Szafran, et al.
The Journal of Biological Chemistry
|
November 6, 2016
Characterization of the interactions between calmodulin and death receptor 5 in triple-negative and estrogen receptor-positive breast cancer cells. AN INTEGRATED EXPERIMENTAL AND COMPUTATIONAL STUDY
Romone M Fancy, Lingyun Wang, Thomas Schmid, et al.
Page
of 16
Search research articles
Search
Showing results (51-60 of 157) with videos related to
Sort By:
Page
of 16
The Journal of Biological Chemistry
|
April 30, 2016
Characterization of the Interactions between Calmodulin and Death Receptor 5 in Triple-negative and Estrogen Receptor-positive Breast Cancer Cells: AN INTEGRATED EXPERIMENTAL AND COMPUTATIONAL STUDY
Romone M Fancy, Lingyun Wang, Qinghua Zeng, et al.
Plos One
|
March 8, 2013
The C-terminal region Mesd peptide mimics full-length Mesd and acts as an inhibitor of Wnt/β-catenin signaling in cancer cells
Cuihong Lin, Wenyan Lu, Wei Zhang, et al.
Pancreas
|
February 26, 2010
A new drug delivery method of bispecific ligand-directed toxins, which reduces toxicity and promotes efficacy in a model of orthotopic pancreatic cancer
Seunguk Oh, Brad J Stish, Selwyn M Vickers, et al.
Cancer Letters
|
April 16, 2014
Multi-targeted therapy of cancer by niclosamide: A new application for an old drug
Yonghe Li, Pui-Kai Li, Michael J Roberts, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 14, 2008
Enhancement of glioma radiotherapy and chemotherapy response with targeted antibody therapy against death receptor 5
John B Fiveash, G Yancey Gillespie, Patsy G Oliver, et al.
The Journal of Surgical Research
|
July 10, 2003
Differential responses by pancreatic carcinoma cell lines to prolonged exposure to Erbitux (IMC-C225) anti-EGFR antibody
Zhi-qiang Huang, Donald J Buchsbaum, Kevin P Raisch, et al.
International Journal of Molecular Sciences
|
March 22, 2018
<sup>212</sup>Pb-Labeled Antibody 225.28 Targeted to Chondroitin Sulfate Proteoglycan 4 for Triple-Negative Breast Cancer Therapy in Mouse Models
Benjamin B Kasten, Patsy G Oliver, Harrison Kim, et al.
Herpes : the Journal of the IHMF
|
December 7, 2006
Oncolytic HSV-1 for the treatment of brain tumours
James M Markert, Jacqueline N Parker, Donald J Buchsbaum, et al.
International Journal of Molecular Sciences
|
May 23, 2018
Preferential Inhibition of Wnt/β-Catenin Signaling by Novel Benzimidazole Compounds in Triple-Negative Breast Cancer
Abhishek Gangrade, Vibha Pathak, Corinne E Augelli-Szafran, et al.
The Journal of Biological Chemistry
|
November 6, 2016
Characterization of the interactions between calmodulin and death receptor 5 in triple-negative and estrogen receptor-positive breast cancer cells. AN INTEGRATED EXPERIMENTAL AND COMPUTATIONAL STUDY
Romone M Fancy, Lingyun Wang, Thomas Schmid, et al.
Page
of 16